Form 8-K · Current report

Boston Scientific 8-K, filed Sep 8, 2026

Filed
CIK
0000885725
Accession no.
0000885725-26-000059
AI-generated summary

Summary

Boston Scientific said a cybersecurity incident identified on August 25, 2026 disrupted its IT systems and global operations, interrupting manufacturing and order processing, and that the incident is likely to materially affect third-quarter and full-year 2026 results, making it unlikely to meet previously issued net sales growth and adjusted EPS guidance; the company reported that its distribution network, sterilization facilities and manufacturing have largely been restored but that full recovery timing is uncertain.

Key points

  • The incident, identified August 25, 2026, caused a network outage affecting access to operating systems and business applications, disrupting manufacturing and the processing and shipping of customer orders.
  • Boston Scientific said it has not identified evidence of ongoing unauthorized access, and its investigation is continuing.
  • Major distribution centers are processing and shipping orders at or above normal levels, sterilization facilities are operational, and manufacturing has resumed at most facilities globally.
  • The company does not expect a material impact on its long-term financial condition, and plans to update its 2026 outlook on its October 28, 2026 third-quarter earnings call.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 1.05Material Cybersecurity Incidents

From the filing

Item 1.05 Material Cybersecurity Incidents. As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation (the “Company”) identified a cybersecurity incident that affected certain of its information technology systems and resulted in a global disruption to the Company’s operations. Upon detection, the Company activated its incident response protocols, and since then has been working, with the assistance of third-party cybersecurity experts, to investigate, assess and contain the impact of the incident and to restore operations. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Boston Scientific in Readster

Add Boston Scientific to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.